NBC SECURITIES, INC.
Broker-DealerPosition in BBIO — BridgeBio Pharma, Inc.
CIK 791540
BIRMINGHAM, AL
Position in BBIO
as of Mar 31, 2026
· filed Apr 14, 2026
Position Value
$229,611
-$39,480 QoQ
Shares Held
3,092
-12.1% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NBC SECURITIES, INC. holds $4,320,734 across 55 Biotechnology names. BBIO ranks #7 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HALO |
Halozyme Therapeutics, Inc.
|
11,280 | $729,026 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
436 | $336,871 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
1,793 | $303,052 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
2,547 | $268,453 | |
| 5 | INBX |
Inhibrx Biosciences, Inc.
|
3,800 | $255,474 | |
| 6 | TSHA |
Taysha Gene Therapies, Inc.
|
54,058 | $241,639 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
This page
|
3,092 | $229,611 | |
| 8 | MIRM |
Mirum Pharmaceuticals, Inc.
|
2,420 | $223,559 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $229,611 | 3,092 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $269,091 | 3,518 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $195,346 | 3,761 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $142,407 | 3,298 | Shares | Sole | 2025-07-08 | |
| No filing history on record for this holder in this stock. | ||||||